On May 3, 2021 Herantis Pharma Plc ("Herantis"), focusing on disease modifying therapies for debilitating neurodegenerative diseases, reported that Dr. Craig Cook, Chief Executive Officer, will hold 1×1 meetings and have a digital company presentation at the following virtual investor conferences (Press release, Herantis Pharma, MAY 3, 2021, View Source,c3338722 [SID1234578960]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event Details:

Redeye Investor Forum Online

Date: 11 May 2021

Bio€quity Europe

Dates: 17 – 19 May 2021

ABGSC Life Science Summit

Date: 25 May 2021

Presentation Time: 11:00 – 11:30 a.m. CEST / 12:00 – 12:30 EEST

All presentations will be available via a digital library, which is accessible to event participants only. Please contact the organizers at the Redeye, Bio€quity Europe, and ABGSC if you wish to attend and/or schedule a meeting with Herantis.